AgilVax
Latest round
- Series A
Last raised
- May 2018
Total raised
- $1.6M
Investors
- 2
About AgilVax
Founded in 2011 and based in New Mexico, US, AgilVax, Inc. operates as a biotechnology company that develops AX09, antibody-based therapy used for cancer treatment.
Who invested in AgilVax
2 investors across 2 rounds
See all investors in AgilVax
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about AgilVax
Who invested in AgilVax?
AgilVax has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has AgilVax raised?
AgilVax has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did AgilVax last raise money?
AgilVax's most recent round on record is a Series A, in May 2018.
What does AgilVax do?
Founded in 2011 and based in New Mexico, US, AgilVax, Inc.
Where is AgilVax headquartered?
AgilVax is headquartered in Albuquerque, US.
Which VCs invest in companies like AgilVax?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at AgilVax's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like AgilVax? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.